NASDAQ:BJDX 9 October 2025

Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement

Bluejay Diagnostics (BJDX) soared up to 213% in premarket trading after announcing a U.S. manufacturing deal with Argonaut for its Symphony test system, but shares remain volatile as Symphony still awaits FDA clearance, clinical enrollment is incomplete, and Bluejay warns it will need more funding within a year or may face liquidation if capital can’t be raised.

2 June 2026

Healthcare News·NASDAQ:BJDX·Stock Market

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics shares soared over 142% to $4.53 on Oct. 9 after announcing an expanded manufacturing partnership with SanyoSeiko. Trading volume hit 40 million shares, far above the 154,000 average. The company, which has no product revenue and only $5.7 million in cash, recently cut its workforce by 90%. Symphony, its lead diagnostic product, is not yet FDA-cleared.

9 October 2025

Healthcare News·NASDAQ:BJDX·Stock Market

Oil Prices Climb on Renewed U.S.-Iran Airstrikes, U.S. Stock Futures Rise
June 28, 2026, 8:36 PM EDT. Oil prices increased on Sunday as the U.S. and Iran exchanged airstrikes in the Persian Gulf, raising concerns over potential disruptions to the Strait of Hormuz, a crucial shipping route. U.S. stock-index futures edged higher amid escalating geopolitical tensions. The developments put energy markets on alert due to possible supply constraints from the strategic waterway.

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026

July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026

IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.

AbbVie stock run lifts pricing on $10.9 billion Apogee deal to six times cost

29 June 2026

AbbVie surged 17% since June 18 to a record $253.35, adding $65 billion in market value—six times its $10.9 billion Apogee buyout—driven by investor demand for long-term immunology growth despite near-term EPS dilution, as Skyrizi won expanded FDA approval and Humira sales fell.

Cisco stock selloff: Friday volume drives 90% of weekly drop before short U.S. market week

29 June 2026

Cisco plunged 4.37% to $113.77 on Friday, erasing $21 billion in market value on volume 2.3 times the recent average, as the stock tracked AI-linked peers instead of the Dow despite strong Q3 results and raised AI order targets; Friday’s close is the live reference for holders ahead of the July 4 holiday-shortened week.

NASDAQ:BJDX 9 October 2025 - 2 June 2026

Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Stock Market Today

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

AbbVie stock run lifts pricing on $10.9 billion Apogee deal to six times cost

Cisco stock selloff: Friday volume drives 90% of weekly drop before short U.S. market week

Latest Video